Guowu Wu

Comprehensive Analysis of the PD-L1 and Immune Infiltrates of m6A RNA Methylation Regulators in Head and Neck Squamous Cell Carcinoma

Lilan Yi, Guowu Wu, Longhua Guo et al. · Molecular Therapy — Nucleic Acids · 2020 · 198 citations · Full text

Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer

Lilan Yi, Ping Huang, Xiaofang Zou et al. · Pharmacological Research · 2020 · 82 citations

Esophageal Cancer, Immune Microenvironment, Medicine +7

Gefitinib Plus Chemotherapy vs Gefitinib Alone in Untreated <i>EGFR</i>-Mutant Non–Small Cell Lung Cancer in Patients With Brain Metastases

Xue Hou, Meichen Li, Guowu Wu et al. · JAMA Network Open · 2023 · 48 citations · Full text

Efficacy, Safety, and Health-Related Quality of Life With Camrelizumab Plus Pemetrexed and Carboplatin as First-Line Treatment for Advanced Nonsquamous NSCLC With Brain Metastases (CAP-BRAIN): A Multicenter, Open-Label, Single-Arm, Phase 2 Study

Xue Hou, Chengzhi Zhou, Guowu Wu et al. · Journal of Thoracic Oncology · 2023 · 47 citations · Full text

Gefitinib (an EGFR tyrosine kinase inhibitor) plus anlotinib (an multikinase inhibitor) for untreated, EGFR-mutated, advanced non-small cell lung cancer (FL-ALTER): a multicenter phase III trial

Huaqiang Zhou, Yaxiong Zhang, Gang Chen et al. · Signal Transduction and Targeted Therapy · 2024 · 25 citations · Full text